Robyn M. Emanuel, M.D., M.P.H., (previously Scherber) is an active researcher focusing mainly in the areas of symptom burden among essential thrombocythemia, polycythemia vera, and myelofibrosis patients.
Dr. Emanuel has been key in the validation of methods to assess symptom burden among myeloproliferative neoplasm patients. Her research has helped to further our understanding of many of the disease symptoms, including spleen-, cytokine-, end-organ- and constitutional- related symptoms present among patient with myeloproliferative disease.
- Investigating symptom burden among the myeloproliferative neoplasm patients. Along with Dr. Ruben Mesa, Dr. Emanuel have been key in the creation of the Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF), a validated measure to evaluate symtoms among patients with myeloproliferative neoplasms.
- Developing novel treatment strategies to improve quality of life among myeloproliferative neoplasm patients. These efforts include investigational trials evaluating the impact of traditional and experimental myeloproliferative neoplasm treatments on symptoms and quality of life.
- Collaborator and Co-Investigator, the Myeloproliferative Neoplasm Quality of Life International Study Group (MPN-QOL ISG). The MPN-QOL ISG an organization devoted to the investigation and coordination of furthering international collaborative trials among myeloproliferative neoplasm patients.
Significance to patient care
Dr. Emanuel is a key investigator in the myeloproliferative neoplasms research program at Mayo Clinic in Arizona, which is led by Dr. Mesa. This comprehensive program is devoted to making an important difference for myeloproliferative neoplasm patients through efforts in clinical practice, education and research.
The research aims to bring the latest drug trials to patients in a holistic manner, with a focus on overcoming the symptomatic burden of having a myeloproliferative neoplasm.
This program focuses on patient education, including the annual Living with Cancer educational symposia.
- American College of Physicians, Arizona Chapter Research Award. Research award given among to the highest ranking competitive abstract presentation among Arizona candidates.
- MD with Distinction in Research Award.
- Abstract Achievement Award. Award intended to recognize achievements related to being a trainee abstract presenter at the 2011 American Society of Hematology, San Diego, CA ($500).
- Leichtling Memorial Oncology Fund Award. Travel award to present the 2011 American Society of Hematology, San Diego, CA.
- Rosalind Franklin University of Medicine and Science Executive Council Travel Award. Competitive travel award through the Executive Student Council awarded to students presenting an abstract at a national conference.
- American Society of Hematology Travel Award. Competitive award to offset the costs of travel to the 2010 American Society of Hematology Conference on Orlando, FL.